Ehsan Taghiabadi1, Sima Nasri2, Saeed Shafieyan3, Sasan Jalili Firoozinezhad3, Nasser Aghdami3. 1. Department of Biology, Faculty of Science, Payame NOOR University, Tehran, Iran ; Department of Regenerative Biomedicine at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. 2. Department of Biology, Faculty of Science, Payame NOOR University, Tehran, Iran. 3. Department of Regenerative Biomedicine at Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Abstract
OBJECTIVE: As a biological tissue material, amniotic membrane (AM) has low immunogenicity and to date has been widely adopted in clinical practice. However, some features such as low biomechanical consistency and rapid biodegradation is limited the application of AM. Therefore, in this study, we fabricated a novel three-dimensional (3D) spongy scaffold made of the extracellular matrix (ECM) of denuded AM. Due to their unique characteristics which are similar to the skin, these scaffolds can be considered as an alternative option in skin tissue engineering. MATERIALS AND METHODS: In this experimental study, cellular components of human amniotic membrane (HAM) were removed with 0.03% (w/v) sodium dodecyl sulphate (SDS). Quantitative analysis was performed to determine levels of Glycosaminoglycans (GAGs), collagen, and deoxyribonucleic acid (DNA). To increase the low efficiency and purity of the ECM component, especially collagen and GAG, we applied an acid solubilization procedure hydrochloridric acid (HCl 0.1 M) with pepsin (1 mg/ml). In the present experiment 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) cross linker agent was used to improve the mechanical properties of 3D lyophilized AM scaffold. The spongy 3D AM scaffolds were specified, by scanning electron microscopy, hematoxylin and eosin (H&E) staining, a swelling test, and mechanical strength and in vitro biodegradation tests. Human fetal fibroblast culture systems were used to establish that the scaffolds were cytocompatible. RESULTS: Histological analysis of treated human AM showed impressive removal of cellular components. DNA content was diminished after treatment (39 ± 4.06 μg/ml vs. 341 ± 29.60 μg/ml). Differences were observed between cellular and denude AM in matrix collagen (478 ± 18.06 μg/mg vs. 361 ± 27.47 μg/mg).With the optimum concentration of 1 mM NHS/EDC ratio1:4, chemical cross-linker agent could significantly increase the mechanical property, and resistance to collagenase digestion. The results of 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS) test showed that cross-linking efficiency of AM derived ECM scaffolds was about 65% ± 10.53. Scaffolds treated with NHS/EDC cross-linker agent by 100 μg/ml collagenase, lost 75% of their dry weight after 14 days. The average pore size of 3D spongy scaffold was 160 µm measured from scanning electron microscope (SEM) images that it is suitable for cell penetration, nutrients and gas change. In addition, the NHS/ EDC cross-linked AM scaffolds were able to support human fetal fibroblast cell proliferation in vitro. Extracts and contact prepared from the 3D spongy scaffold of AM showed a significant increase in the attachment and proliferation of the human fetal fibroblasts cells. CONCLUSION: The extra-cellular matrix of denuded AM-based scaffold displays the main properties required for substitute skin including natural in vitro biodegradation, similar physical and mechanical characterization, nontoxic biomaterial and no toxic effect on cell attachment and cell proliferation.
OBJECTIVE: As a biological tissue material, amniotic membrane (AM) has low immunogenicity and to date has been widely adopted in clinical practice. However, some features such as low biomechanical consistency and rapid biodegradation is limited the application of AM. Therefore, in this study, we fabricated a novel three-dimensional (3D) spongy scaffold made of the extracellular matrix (ECM) of denuded AM. Due to their unique characteristics which are similar to the skin, these scaffolds can be considered as an alternative option in skin tissue engineering. MATERIALS AND METHODS: In this experimental study, cellular components of human amniotic membrane (HAM) were removed with 0.03% (w/v) sodium dodecyl sulphate (SDS). Quantitative analysis was performed to determine levels of Glycosaminoglycans (GAGs), collagen, and deoxyribonucleic acid (DNA). To increase the low efficiency and purity of the ECM component, especially collagen and GAG, we applied an acid solubilization procedure hydrochloridric acid (HCl 0.1 M) with pepsin (1 mg/ml). In the present experiment 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) cross linker agent was used to improve the mechanical properties of 3D lyophilized AM scaffold. The spongy 3D AM scaffolds were specified, by scanning electron microscopy, hematoxylin and eosin (H&E) staining, a swelling test, and mechanical strength and in vitro biodegradation tests. Human fetal fibroblast culture systems were used to establish that the scaffolds were cytocompatible. RESULTS: Histological analysis of treated human AM showed impressive removal of cellular components. DNA content was diminished after treatment (39 ± 4.06 μg/ml vs. 341 ± 29.60 μg/ml). Differences were observed between cellular and denude AM in matrix collagen (478 ± 18.06 μg/mg vs. 361 ± 27.47 μg/mg).With the optimum concentration of 1 mM NHS/EDC ratio1:4, chemical cross-linker agent could significantly increase the mechanical property, and resistance to collagenase digestion. The results of 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS) test showed that cross-linking efficiency of AM derived ECM scaffolds was about 65% ± 10.53. Scaffolds treated with NHS/EDC cross-linker agent by 100 μg/ml collagenase, lost 75% of their dry weight after 14 days. The average pore size of 3D spongy scaffold was 160 µm measured from scanning electron microscope (SEM) images that it is suitable for cell penetration, nutrients and gas change. In addition, the NHS/ EDC cross-linked AM scaffolds were able to support human fetal fibroblast cell proliferation in vitro. Extracts and contact prepared from the 3D spongy scaffold of AM showed a significant increase in the attachment and proliferation of the human fetal fibroblasts cells. CONCLUSION: The extra-cellular matrix of denuded AM-based scaffold displays the main properties required for substitute skin including natural in vitro biodegradation, similar physical and mechanical characterization, nontoxic biomaterial and no toxic effect on cell attachment and cell proliferation.
The skin, which is the largest tissue in human body,
is constructed of three layers epidermis, dermis and
hypodermis. It performs a main function in protecting
the human body from much chemical and mechanical
damage from the surrounding environment. The loss
of skin can occur for various reasons, such as thermal
trauma, genetic disorders, chronic wounds, burns or
even surgical interventions (1). Because of the low
immunogenicity of donor skin and the limited availability
of donor skin sources, skin grafts are unable
to provide complete recovery of the skin rendering
them unsuitable for widespread use. Several years
ago, great attempts were made to fabricate substitute
human skin. Tissue engineering is an impressive way
to develop skin substitutes and improve the wound
healing. One fundamental purpose of cell biologists
in tissue engineering is to induce cell proliferation
using appropriate cell culture conditions (2, 3). The
aim of study to construct a novel three-dimensional
(3D) scaffold that improves cell proliferation and
imitates the structure of the skin. Collagen is a main
component of human connective tissues, particularly
in soft skin tissues (4). Collagen is one of the best
biomaterials for different applications (5, 6). Advantages
include excellent biocompatibility, low toxicity
and excellent biodegradability (7, 8). Despite these
advantages, low mechanical consistency and the fast
degradation rate of uncross-linked natural scaffolds
such as collagen are the main problems that restrict
its application. Thus, cross-linking of the collagen
scaffolds is an impressive procedure to optimize their
mechanical strength and to regulate the biodegradation
rate. Glycosaminoglycans (GAGs) are another
principal component of the skin tissue that is associated
with skin repair. Being the most hydrophilic
molecule exist in the natural tissue such as skin, this
characteristic GAGs is of vital role in water maintenance
(9). GAGs can be better modified by functional
groups such as hydroxyl and carboxyl chains (10).
GAGs also perform general functions in intermediary
skin-cell biological procedures, cell migration,
growth, granulation tissue matrix formation, inflammatory
response temperance, re-epithelialization and
scarring (11). In addition, cellular attachment, growth
and differentiation depends on denatured collagen
structure.Human amniotic membrane (HAM) has alots of
specifications that cause it applicable biomaterial.
The extra cellular matrix of amnion composed of
collagen I, collagen III, collagen IV and fibronectin.
It is cheap and quickly takes, and its availability
is virtually unrestricted. HAM has been presented
to consult applicable wound protection and
have a symbolic outcome on pain reduction (12).
3D natural and synthetic scaffolds play a main
function in maintenance of cell proliferation and
tissue regeneration (13). Interactions between cells
and the extracellular matrix (ECM) are responsible
for the control of cell action. So, cells grown
in a 2D monolayer cannot cope with the relative
complexity of the in vivo micro-environment. For
example, it has been suggested that cells cultivated
on 2D layer such as culture plates, lose numerous
critical signals, important regulators, and tissue
phenotypes. Cells growing in 3D have different
propagation capacity, extracellular matrix synthesis,
cell congestion, and metabolic functions (13).In general, easily degradation components of AM
causesa loss of mechanical property (14). So, our
hypothesize in this study, are cross-linking ECM
components may change the degradation rate and
biomechanical specifications, thus improving their
biocompatibility. The procedure of cross-linking
natural scaffolds is the best method for improving
the mechanical features. Commonly, there are two
different technique for this purpose: physical procedure
and chemical treatment (14, 15). Chemical
cross-linking procedure is an appropriate method
compared with physical procedure because of high
mechanical strength and biodegradation rate (16).
1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide
hydrochloride (EDC)/N-hydroxysuccinimide
(NHS) is great interest and zero-length cross-linking
agent because of two different reactive groups
that are able straightly join 2 different amino acid
side chains (15, 16). The cross-linking of bio-scaffolds
has become one of the most suitable strategies
for the bio-porous matrix. Commonly, there
are two types of cross-linking methods often applied
in improving the mechanical properties:
physical treatments and chemical techniques (14,
15). Physical treatments generally cannot output
a high enough cross-linking degree to meet the
demands for mechanical strength and biodegradation
rates, therefore, treatments by chemical
techniques are still essential in most cases (16). A
cross-linking agent, EDC/NHS is of great interest
in maximizing the extent of cross-linking because
it contains 2 different reactive groups that are able
to directly link 2 various amino acid side chains, and it is a zero-length cross-linking agent (15,
16). Therefore, we fabricated 3D spongy scaffold
derived amniotic membrane (AM) specially
collagen component with chemical cross-linker
NHS/EDC. The porosity of sponge-like scaffold
was assessed by in vitro cultured of human fetal
fibroblasts (FBs).
Materials and Methods
Harvest and preparation of HAMs
In this experimental study, after written informed
consent was obtained, human placentas were taken
from HAMs bank, part of the public cord blood bank
in the Royan Institute, with Ethical Committee Approval.
All placenta donors were serologically negative
for human immunodeficiency virus, hepatitis virus
type B, hepatitis virus type C, and syphilis.The placentas were washed 3 times by phosphate-
buffered saline (PBS, pH=7.4, Gibco, USA)
in a class 2 laminar flow. After separation of AM
from the underlying chorionand cut into pieces of
approximately 5×5 cm2. The pieces were stored in
PBS containing 1.5% dimethyl sulfoxide (DMSO)
at -70˚C for up to five months.
Decellularization of HAM
The HAM was thawed then rinsed 3 times with
PBS (Gibco, USA) and then incubated in hypotonictris buffer (10 mM tris) (Merck, Germany), pH=8.0
including ethylenediaminetetraacetic acid (EDTA,
0.1% w/v) (Sigma, USA) at 4˚C for 16 hours. The
AM was then put in 0.03% (w/v) solution sodium dodecyl
sulphate (SDS) (Merck, Germany) in tris-buffered
saline (TBS) (Sigma, USA) containing EDTA
(0.1% w/v, pH=7.6) and shaken at room temperature
for 24 hours. In the next step, the AM was washed
in TBS (pH=7.6). The AM was incubated in a buffer
contain [50 mM trishydrochloric acid (HCl), 10 mM
magnesium chloride], pH=7.5, (Sigma, USA) for 3
hours at 37˚C, on the shaker, then rinsed 3 times with
PBS (Gibco, USA) (17).
DNA quantitative assay
A DNA quantitative assay was undertaken in five
denuded AM samples selected randomly, with total
DNA extracted using a DNA assay kit (Roche,
Germany) according to the manufacturer’s instructions.
Optical density (OD) was measured at 260
nm with a micro-plate fluorescence reader (Thermo,
USA). A standard curve was mapped to calculate
the DNA concentration. Intact AM was used
as the control.
Manufacturing AM spongy scaffold
A solution of HCl 0.1 M, pepsin and freeze dried
powder of acellular HAM were mixed to a final
concentration of, 1 mg/ml, and, respectively. The
mixed solution was added into a 24 wells and
frozen at −70˚C for 24 hours. The scaffold size
could be adjusted by (regulating) the appropriate
volume of the (constructing) solution. The sponge
AM scaffold was fabricated by lyophilizing for 24
hours (18). The procedure of cross-link was done
for 24 hours at 25˚C in ethanol 95% (Merck, Germany)
containing 1 mM NHS/EDC (Sigma, USA)
with a ratio of 1:4. Afterwards, the cross-linking
reaction was stopped by elimination of NHS/EDC
solution and adding with 0.1 M Na2HPO4 solution
then washing with distilled H2O more three times
remove un-reacted chemicals. The scaffold was
lyophilized for another 24 hours and sterilized by
ethanol 70% (Merck, Germany).
Histology and microscopy
Cellular AM, acellular AM and 3D spongy scaffold
for light microscopy were fixed using 10%
(w/v) neutral-buffered formalin (Sigma, USA) dehydrated
and embedded in paraffin wax. Sections
were cut using a microtome at 6 μm and stained
with hematoxylin and eosin (H&E), collagen,
GAGs and Russell-Movat stain. All histological
sections were viewed using an olympus BX71
light microscope (Olympus, Germany).
Collagen analysis
An estimation of the collagen content of the experimental
groups including intact AM, denuded
AM and 3D spongy AM scaffold was made by
determining the hydroxyproline content in acidhydrolyzed
samples by acid/pepsin-soluble Sicrol
collagen assay kit (Biocolor, UK) according to the
manufacturer’s instruction. For extraction of acid/
pepsin soluble collagen, samples were digested
with 0.5 M acetic acid containing 1 mg/ml (w/v)
pepsin (Sigma, USA) overnight at 4˚C. The supernatant
of digested suspension was incubated with
1 mL Sircol dye reagent for 30 minutes at room
temperature. Hydroxyproline levels were obtained
by measuring absorbance at 555 nm. All contents were normalized with 0.5 mg of dry AM.
GAG analysis
The GAG content of acid-hydrolyzed experimental
groups was determined using sulfated GAG
kit (Biocolor, UK) according to the manufacturer’s
instruction (19, 20). GAG levels were obtained by
measuring absorbance at 656 nm and extrapolating
values from a standard curve of chondroitin sulphate
B (Blyscan, UK). Data is expressed as μg/
mg of AM groups.
Determination of extent of cross-linking
The 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) assay
was used to determine the amount of free amino
groups in each of the experimental AM groups. The
test samples were weighed and reacted with 0.5 ml of
a 4% (w/v) NaHCO3 solution and 0.5 ml of a freshly
made solution of 0.05% (w/v) TNBS. After reaction
for 2 hours at 40˚C, 1.5 ml of 6 M HC1 was added
and the samples were hydrolyzed at 60˚C for 90 minutes.
The reaction mixture was diluted with distilled
water (2.5 ml), cooled to room temperature and the
absorbance at 420 nm was measured using a microplate
fluorescence reader (Thermo, USA). Controls
(blank samples) were prepared using the same procedure,
except that HCl was added prior to the TNBS
solution. The absorbance of the blank samples was
subtracted from each sample absorbance. The absorbance
was correlated to the concentration of free
amino groups using a calibration curve obtained with
glycine in an aqueous NaHCO3 solution (0.1 mg/ml),
where the relationship between absorbance and concentration
of primary amino groups was expressed
as percent. The extent of cross-linking of 3D spongy
scaffold was calculated using the following equation
(21). Results were the average of five independent
measurements.
Scanning electron microscopy
After fixation of scaffolds in 2.5% glutaraldehyde
and 0.1 M sodium phosphate buffer, pH=7.2
for 12 hours , scaffolds were immersed in 1% osmium
tetroxide for 1 hour, dehydrated in ethanol
and dried. Then, the scaffolds were subjected to
scanning electron microscopy (18). For scanning
electron microscope (SEM), the 3D spongy AM
scaffold was further dried with carbon dioxide in
a critical point dryer (Balzers, Liechtenstein) and
coated with gold in a sputter coater (Hitachi, Tokyo,
Japan) before examination under a KYKYEM3200,
Germany, SEM with an accelerating
voltage of 24 kV. For assessment average pore size
of scaffolds, the poresize of 30 pores on each of
the 5 SEM photos were measured.
In vitro collagenase degradation
Collagenase cleaves triple helical collagen at a
specific site of chains (Gly 775-Leu/Ile 776). Dry
spongy scaffolds (40 mg/ml) were floated at 6 well
cell culture containing 1 ml of PBS buffer (pH=7.4,
Gibco, USA) with collagenase (100 μg/ml) for
3, 7, 14, and 21 days. A reaction was incubated
at 37˚C. At the end of the test periods, the weight
of residual dry spongy scaffolds was assessed following
three times washing in distilled water and
finally lyophilization. The rate of degradation was
calculated from the weight of the remaining scaffold.
The control group was untreated scaffold.
PBS swelling property
The water absorption capacity of the AM scaffolds
were specified by swelling scaffolds in PBS
at 37˚C, pH=7.4. The scaffolds with (40 mg) were
separately immersed into PBS solution for 5 minutes,
1, 2, 3, 4, 5, 6, 24, 48 and 72 hours. The water
of scaffolds were re moved and then weighed. For
calculation of water absorption in the swollen scaffold
was used of this equation:Ww=weight of the swollen scaffold, and Wd =weight
of the dry scaffold (18).
Cell viability assay-MTS test
MTS assessment applied in this study for evaluation
of cell viabilities and proliferation rate (22). Fetal
fibroblasts (104 cells/well) were seeded in 96-well
plates for 72 hours at 37˚C. After 72 hours complete
culture medium was removed. Then 200 μl of Culture
medium and MTS solution (Promega, USA) in a proportion of 5:1 were exposed for 3 hours at 37˚C in
a humidified atmosphere containing 5% CO2. After
this time, absorbance was measured at 490 nm with a
plate reader (Thermo, USA).
Biocompatibility of 3D spongy HAM scaffold
Human fetal fibroblast proliferation and cell
metabolic activities in scaffolds was assessed by
measuring the mitochondrial dehydrogenase activity
using 3-(4, 5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium
(MTS) assay (Sigma, USA), according
to the manufacturer’s protocol. Scaffolds were located
in 24-wells plates. Cells were seeded on the
scaffolds (105 cells in 400 ml per well) and cultured
for 3, 7, 14 and 21 days at 37˚C/ 5% CO2 in fibroblast medium (10% (v/v) fetal bovine serum,
4 mM glutamine, penicillin (100 U/ml) and
streptomycin (100 mg/ml) in Dulbeccoʼs Modified
Eagle Medium: Nutrient Mixture F-12 (DMEM/
F12). After the addition of 20 μl MTS per well
and subsequent incubation for 3 hours at 37˚C, 5%
CO2, the absorption was measured at 490 nm (23).
Cell morphology
Cell morphology was distinguished using SEM.
15 mm scaffolds were put in 24-well culture dishes
and cells were seeded on top. Human fetal fibroblasts
were cultivated on the airside of the scaffolds
with a density of about 105 cells per cm2 in
fibroblast medium (10% (v/v) fetal bovine serum,
4 mM glutamine, penicillin (100 U/ml), and streptomycin
(100 mg/ml) in DMEM/F12. Cells were
cultivated at 37˚C and 5% CO2 for 7 days. After
7 days, scaffolds were fixed by immersion in 2%
(v/v) glutaraldehyde in 0.1% osmium tetroxide for
1 hour, dehydrated in ethanol and dried. Then, the
scaffolds were subjected to scanning electron microscopy.
At every indicated time interval (3, 7, 14
and 21 days), the scaffolds were collected for experimental
analysis.
Cell metabolic activities in scaffolds
Cells in scaffolds were quantitatively evaluated
with MTS assay at 3, 7, 14 and 21 days. 100 μl of
culture medium was aspirated at 3, 7, 14 and 21
days, then supplemented with 20 μl of MTS solution
in 96 plates and incubated at 37˚C for 3 hours.
200 μl of supernatant was used to measure optical
density spectrophotometrically at 490 nm (20, 22),
using a microplate reader (Thermo, USA).
Statistical analysis
Statistical significance was assessed using oneway
analysis of variance (ANOVA), and the minimum
significant difference between individual
group means was calculated using the t test method.
For a comparison of 2 groups, a 2-tailed unpaired
student t test was used. Values of p less than
0.05 were considered significant. All data were
reported as mean ± standard deviation (SD) (n=5).
Results
Histological comparison of intact and denuded
HAMs
Intact and denuded HAMs were stained using
H&E and dyes to determine whether the treatment
successfully eliminated cellular components. For
routine histology, all samples were embedded using
paraffin wax and sectioned and 5 sections at
6 μm were obtained and stained. H&E staining
confirmed that the procedure was successful and
no cells were visible (Fig 1A, B). Russell MOVAT
staining demonstrated no obvious disruption
to the sum of matrix histoarchitecture following
treatment; the main structural component of HAM
(collagen) appeared to have been preserved after
decellularization (Fig 1C, D).
Fig 1
Decellularization of human amniotic membrane (HAM): hematoxylin- and eosin (H&E)-stained native HAM (original
magnification: ×20) Intact HAM (A), 0.03% (w/v) sodium dodecyl sulphate (SDS)-treated HAM (original magnification: ×20)
(B), in each image, the arrows are indicating the apical surface of the HAM. Extracellular matrix (ECM) compositions were
showed in intact AM, dendued AM and 3D AM scaffold (C, D) by using Russell-Movat staining (collagen, yellow) and (GAG,
Green), Deoxyribonucleic acid (DNA) content of intact and denuded HAM was quantified using a micro plate fluorescence
reader (E). Statistical differences between intact and denuded HAM groups; analysis of ECM components, including acid/
pepsin-soluble collagen, sulfated GAG (F, G). Statistical differences between collagen and GAG contents of intact HAM and 3D
AM scaffold. (Data are shown as mean ± standard deviation), n=5 , A; P<0.001 and GAG; Glycosaminoglycan.
Quantification of residual DNA following decellularization
The DNA content of HAM before treatment was
determined as (341 ± 29.60 μg/ml). After the decellularization
procedure, a significant decline to
(39.38 ± 4.04 μg/ml) was observed (n=6, p<0.05,
ANOVA, Fig 1E).
Collagen and GAG analysis
Biochemical assays were undertaken to evaluate
the ECM components after decellularization. The
hydroxyproline content of intact AM was found to
be (361 ± 27.39 μg/mg); after treatment, a significant
increase to 478 ± 14.42 μg/mg (n=5, p<0.05,
ANOVA) was observed (Fig 1F). GAGs form the
major structural components of the ECM of tissues;
their abundance in intact AM was found to be
85 ± 3.29 μg/mg. After treatment, a significant decrease
to 43 ± 3.08 μg/mg (n=5, p<0.05, ANOVA)
was observed (Fig 1G).Decellularization of human amniotic membrane (HAM): hematoxylin- and eosin (H&E)-stained native HAM (original
magnification: ×20) Intact HAM (A), 0.03% (w/v) sodium dodecyl sulphate (SDS)-treated HAM (original magnification: ×20)
(B), in each image, the arrows are indicating the apical surface of the HAM. Extracellular matrix (ECM) compositions were
showed in intact AM, dendued AM and 3D AM scaffold (C, D) by using Russell-Movat staining (collagen, yellow) and (GAG,
Green), Deoxyribonucleic acid (DNA) content of intact and denuded HAM was quantified using a micro plate fluorescence
reader (E). Statistical differences between intact and denuded HAM groups; analysis of ECM components, including acid/
pepsin-soluble collagen, sulfated GAG (F, G). Statistical differences between collagen and GAG contents of intact HAM and 3D
AM scaffold. (Data are shown as mean ± standard deviation), n=5 , A; P<0.001 and GAG; Glycosaminoglycan.
Scaffold characteristics
The main structural component of HAM (collagen)
was showed by Russell MOVAT staining
(Fig 2A). The thickness of 3D spongy scaffold
in this study was about 4 mm to mimic the real
thickness of human skin. The SEM observation
results (Fig 2B) showed the morphological
characteristics of the 3D spongy AM scaffolds.
The scaffold disclosed extremely interconnected
porous structures, and the pore wall surface
appeared rough and homogeneous (Fig 2C, D).
SEM images of cross-linked 3D spongy AM
scaffolds indicated that it had an open porous
structure with pores ranging from 44 to 160 μm.
The mean pore size was 90 μm and the average
porosity was 90%, that is suitable for cell penetration,
nutrients and gas change.
Fig 2
3D AM scaffold using Russell- Movat staining (collagen, yellow) and (GAG, Green) (A). Cross linked ECM
derived AM scaffold produced by freeze dryer (B). SEM image of the surface (C). The cross section of the porous (D).
PBS swelling ratio of ECM derived human AM scaffolds at different times (E). In vitro collagenase biodegradation; time
course of weight remaining of ECM derived HAM scaffold, cross-linked with ratio (1:4) of NHS/EDC, after incubation
in PBS containing 100 μg collagenase I, at 37˚C (F). Comparison results of effect of extract cytotoxicity of TCPs and
scaffold groups on viability fetal fibroblast cells by MTS assay extract showed, (p>0.05) (G). (Data are shown as mean ±
standard deviation). ECM; Extracellular matrix, AM; Amniotic membrane, GAG; Glycosaminoglycan, SEM; Scanning
electronic microscopy, EDC; 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride, NHS; N-hydroxysuccinimide,
PBS; Phosphate-buffered saline, TCP; Tissue culture plates, n=5, A; P<0.001 and C; P<0.05.
Cross-linking degree
Cross-linking of biological tissue materials
using water-soluble carbodiimide has received
much attention in the field of biomaterials science
(24). Therefore, the 3D spongy AM scaffolds
were cross-linked with EDC/NHS according
to the general reaction mechanism. The
results of the TNBS test showed that the crosslinking
efficiency of AM derived ECM scaffolds
was about (65% ± 10.53).
PBS solution adsorption
We applied the swelling ratio test to assess water
absorption capability and showed (Fig 2E)
that without NHS/ EDC cross-linking, scaffolds
dissolved in water within 2 minutes and couldnʼt
maintain solid constructions. Our ECM components
of 3D spongy AM scaffold cross-linked with
NHS/ EDC presented a swelling ratio of approximately
5 fold compared with dry weight scaffold.
The results showed highly increased swelling ratios
at 5 minutes. Significant differences in swelling
ratios were not observed at other selected time
intervals (Fig 2E).The biological degradation of the 3D AM
sponge-like scaffold was characterized by
measuring the decrease in weight. The rates
were tested by in vitro enzyme assays using collagenase
I. Figure 2F shows that 100 μg/ml of
collagenase I solution decomposed the scaffold
gradually over three weeks. The scaffold was
29.344 ± 4.87% of the original weight after 21
days of treatment. In vitro enzyme biodegradations
were evaluated to show the time dependences
of this scaffold.
Proliferation of cells directly in contact with scaffolds
The extract cytotoxicity assay distinguished
the effect of soluble components of 3D spongy
AM scaffold on the viability of primary human
fetal dermal fibroblasts cells. Incubation
of primary human fetal dermal fibroblasts with
soluble extracts from intact AM, 3D spongy
AM scaffold and tissue culture plate (TCP) displayed
different levels of cell viability according
to MTS assay. Extracts prepared from the
3D spongy AM scaffold, showed no significant
difference in the viability of the fetal fibroblasts
cells compared to the TCP group (cells-only
negative control) and 3D spongy AM scaffold
after 14 and 21 days (n=6, p>0.05, ANOVA).
The extracts from the 3D spongy AM scaffold
did not display significant adverse effects on
the viability of the fetal fibroblasts cells (Fig
2G).The cell morphology of fibroblasts was studied
on the scaffolds after 7 days of culturing. SEM
images indicated fibroblast cells formed normal
spindle-shaped cells on all scaffolds (Fig 3A, B).
As shown H&E images of scaffold without cell
(Fig 3C, D) and fibroblast cells were able to penetrate,
attach and grow into the 3D structures of 3D
spongy AM scaffold (Fig 3E, F) because of the
presence of large pores.
Fig 3
SEM images of fetal fibroblast cells attached (arrows are indicating fibroblast cells) to ECM derived HAM scaffolds, after 7 days
at surface (A) and internal surfaces of 3D spongy scaffold (B) obtained by cross sectioning. H&E images before and after seeding cells,
The light microscopy images of H&E images showed the external surface of scaffold without cell (C) and attachment of human fetal
fibroblast cells at external surfaces of scaffold, the arrows are indicating attachment of fetal fibroblast cells, the cells are dark grey and
the AM scaffolds are light red (D). H&E images show the internal surface of the scaffold without cell (E) attachment and growth of
fetal fibroblast cells at internal surface of scaffold after 7 days (F). MTS results showed the metabolic activities of fetal fibroblast cells in
ECM derived HAM scaffold. Statistical differences in metabolic activity at days 7, 14 and 21 with 3D HAM scaffold in days 3 (G). SEM;
Scanning electronic microscopy, ECM; Extracellular matrix, HAM; Human amniotic membrane, H&E; Hematoxylin and eosin. (Data
are shown as mean ± standard deviation (SD). (n=5, A; P<0.001 and B; P<0. 01).
Cell metabolic activity of fetal fibroblast cells
in 3D spongy AM scaffolds were evaluated at
every indicated time interval based MTS assay
(Fig 3G).The results of metabolic activity of
human fetal fibroblast cells in 3D spongy AM
scaffolds showed an increasing trend over 7, 14,
and 21 days, but no significant differences were
observed during 3 and 7 days of incubation.3D AM scaffold using Russell- Movat staining (collagen, yellow) and (GAG, Green) (A). Cross linked ECM
derived AM scaffold produced by freeze dryer (B). SEM image of the surface (C). The cross section of the porous (D).
PBS swelling ratio of ECM derived human AM scaffolds at different times (E). In vitro collagenase biodegradation; time
course of weight remaining of ECM derived HAM scaffold, cross-linked with ratio (1:4) of NHS/EDC, after incubation
in PBS containing 100 μg collagenase I, at 37˚C (F). Comparison results of effect of extract cytotoxicity of TCPs and
scaffold groups on viability fetal fibroblast cells by MTS assay extract showed, (p>0.05) (G). (Data are shown as mean ±
standard deviation). ECM; Extracellular matrix, AM; Amniotic membrane, GAG; Glycosaminoglycan, SEM; Scanning
electronic microscopy, EDC; 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride, NHS; N-hydroxysuccinimide,
PBS; Phosphate-buffered saline, TCP; Tissue culture plates, n=5, A; P<0.001 and C; P<0.05.SEM images of fetal fibroblast cells attached (arrows are indicating fibroblast cells) to ECM derived HAM scaffolds, after 7 days
at surface (A) and internal surfaces of 3D spongy scaffold (B) obtained by cross sectioning. H&E images before and after seeding cells,
The light microscopy images of H&E images showed the external surface of scaffold without cell (C) and attachment of human fetal
fibroblast cells at external surfaces of scaffold, the arrows are indicating attachment of fetal fibroblast cells, the cells are dark grey and
the AM scaffolds are light red (D). H&E images show the internal surface of the scaffold without cell (E) attachment and growth of
fetal fibroblast cells at internal surface of scaffold after 7 days (F). MTS results showed the metabolic activities of fetal fibroblast cells in
ECM derived HAM scaffold. Statistical differences in metabolic activity at days 7, 14 and 21 with 3D HAM scaffold in days 3 (G). SEM;
Scanning electronic microscopy, ECM; Extracellular matrix, HAM; Human amniotic membrane, H&E; Hematoxylin and eosin. (Data
are shown as mean ± standard deviation (SD). (n=5, A; P<0.001 and B; P<0. 01).
Discussion
AM is applied in surgery particularly for the reconstruction
of traumatic wounds and skin transplantation
(12). HAM is an appropriate substitute
for general skin for surgical use due to its availability,
low cost, and low risk of viral disease transmission
and immunologic rejection. Basement
membrane in human placenta-derived ECM could
perform a functional component in the well regeneration
of damaged basement membrane skin
tissue, adjust fibroblast and keratinocyte development
and differentiation, and construct epithelial
tissue (12). For a logical design of scaffolds for
skin engineering, it is fundamental to study the
features and effect of individual components of
biomaterial. The overall aim of this study was to
develop an acellular matrix scaffold suitable for
tissue engineering applications in the form of a 3D
scaffold and as a cell delivery system (24). The decellularization
procedure must eliminate the main
sources of immunogenic response including cellular
components, membrane antigens, and soluble
proteins, so blocking initiation of immune response
and later latest degradation of the acellular
matrix transplanted in to the patient (17). A number
of methods for the removal of cells from HAM
have been investigated with varying degrees of
success (25, 26). In most cases, when assessing
cell removal and maintenance of matrix structure,
the methods used failed to remove all of
the cells and cellular components from the tissue
matrix. In this experiment, the decellularization
procedure of was accomplished according
to a modified protocol that has been previously
used on HAM (17).The AM was decellularized by EDTA, SDS in
two steps without the use of nuclease (DNAse and
RNAse) unlike in other studies (17), and were
impressive in terms of elimination of the cellular
component. During the decellularization procedure
in this study the hypotonic buffer lyses the
cells by swelling the water in the cells and SDS,
which is an ionic detergent, attaches to cell membranes
and causes the destruction of the lipid bilayer.
EDTA and the pH of the buffers blocked the
activation of proteases during cell lysis (17). Results
of the procedure to eliminate cells from HAM
showed the loss of cells but retention of DNA in
the matrix.Results of the hydroxyproline assays (Fig 1F)
indicated that the decellularization process did not
lead to loss of collagen, elastin, or GAG content
of the tissue. There was a statistically significant
increase in all the structural components; this increase
was probably as a result of extraction (by
dry weight) of other soluble constituents (soluble
proteins, lipids, nucleic acids).Assessment of the hydroxyproline content using
a collagen kit (Fig 1F) and Russel MOVAT staining,
(Fig 1A, B), (Fig 2A) showed that the decellularization
method did not lead to a decrease of the
collagen contentin the AM. Collagen is an important
component for cell proliferations and tissue
body formation. It provides some of the mechanical
properties such as adhesive and tensile strength.
There was a statistically significant increase in this
structural component of ECM compared to intact
AM; the main reason for this increase maybe an
elicitation of other soluble protein and lipids constituents.Cultivation of cells in 2D monolayer cannot
provide an adequate in vivo micro-environment
for proliferation (26, 27). To fabricate an appropriate
3D scaffold in skin tissue engineering, various
definitive factors to consider include pore size
range, mechanical strength, biodegradability. AM
dissolves because of endogenous enzymatic degradation
of AM matrix during 1 week (28). For
better use of AM in tissue engineering, it should
be reinforced against enzymatic degradation. Collagen
fibers constitute the main structure of AM
which can easily undergo cross-linking, by bridges
are made between the collagen chains (29, 30). Recently,
EDC/NHS one of the cross-linker agents,
has been utilized to improve mechanical properties
in collagen (10), collagen-chitosan (11), and
collagen-phosphorylcholine to obtain suitable tissue
engineered corneal substitutes. NHS/EDC are
presumed to be water-soluble and non-toxic crosslinking
agents because they can be made from urea
derivatives (15). Cross-linking has been confirmed
to play a main role related to the porous structure
distribution of the scaffold and water absorption.
For this experiment, the 3D spongy AM scaffold
was generated through lyophilization (Fig 2B). After
cross-linking, this scaffold did not dissolve in
water and was able to maintain its structure the culture
medium. The swelling ratio results at selected
time intervals disclosed that the scaffold possessed
excellent porous lamellar matrix spaces which increased the water containing capacity. Because of
the high water absorption feature, the sponge-like
matrices were optimal for cells to culture in (27).The degradation data presented gradual weight
loss of the scaffold at selected time intervals (Fig
2F). Our scaffold was composed by NHS/EDC,
was degraded by collagenase I and after it had decomposed;
the scaffold lost its structural properties.When constructing the skin graft, the establishment
of the dermis over the model was apparently
accelerated by the application of skin
cells to the graft (28). Fibroblast cells perform
active roles in a diversity of biological procedures
such as the production of collagen, GAG
and ECM proteins. In particular, fibroblast cells
produce intra/extracellular cytoskeleton tension
forces which allow for interaction with the ECM
(29). SEM observations showed the fetal fibroblast
cells seeded in the scaffold that they proliferated
normally, confirming the benefit of these
materials to cell growth (Fig 3A, B).The interconnected pores within the scaffold
provided the space status for interactions of biological
cytokines and growth factors released from
keratinocyte and fibroblast cells (30, 31).The resulting
data from seeding fetal fibroblast cells on
the scaffold was significant proliferation on the
day 21compared to 3 day, which displayed that
not only the cell proliferation was promoted, but
the individual collagen constructing abilities were
also enhanced (Fig 3G). As our scaffold has demonstrated
the ability to increase collagen secretion,
it is potentially a good biomaterial for wound healing
in skin tissue engineering. Our 3D spongy AM
scaffold hasexcellent potential because of its suitable
pore size, the great swelling ratio and good cytocompatibility.
The skin medicine and therapeutic
wound dressing market is significant. Bio-functions
of traditional dressings in the past are only
for keeping the wound dry and preventing infection.
In clinical applications, we know that moist
and warm surroundings aid repair of wounds to the
skin. Effective scaffolds must investigate several
main factors including skin tissue evaluation s, tissue
deficiency managements, humidity containing
equilibrium, infection preventions, inflammation
controls and dermatological wound edge progression
enhancing in animal model. Other issues that
need to be considered are; the patient healthy conditions
(e.g. diabetes, burns), the injury type being
created by physical or chemical damage, and the
environmental properties. We will continue focusing
on these important options about skin tissue engineering
skin wound dressings in future studies.
Conclusion
A diversity of biological scaffolds has been made
with distinctive biochemical, biomechanical, and
morphological properties. Different procedures
may be used to fabricate organ-specific scaffolds
for tissue engineering. In this study, HAM-derived
ECM scaffolds composed of various ECM components
were created as a biological scaffold for skin
tissue engineering. Human ECM scaffolds were
constructed from HAM via pulverization, decellularization,
and lyophilization. We found that the
sponge-like AM-derived ECM scaffold provided
an optimal pore size and water absorption for human
skin cell growth. This scaffold could be degraded
by collagenase I, which demonstrates its
biodegradability. Our results show that HAM-derived
ECM scaffold could be useful in skin tissue
engineering due to its physico-mechanical properties,
which may improve the quality of wound
healing.
Authors: Carla A Brohem; Laura B da Silva Cardeal; Manoela Tiago; María S Soengas; Silvia B de Moraes Barros; Silvya S Maria-Engler Journal: Pigment Cell Melanoma Res Date: 2010-11-09 Impact factor: 4.693
Authors: P J E Uijtdewilligen; E M M Versteeg; C Gilissen; S V van Reijmersdal; R Schoppmeyer; R G Wismans; W F Daamen; T H van Kuppevelt Journal: J Tissue Eng Regen Med Date: 2013-03-07 Impact factor: 3.963